We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$142M
AUM Growth
+$7.01M
Cap. Flow
+$2.15M
Cap. Flow %
1.52%
Top 10 Hldgs %
59.23%
Holding
36
New
9
Increased
4
Reduced
14
Closed
9

Top Sells

Rank Stock Value
1
IBKR icon
Interactive Brokers
IBKR
+$8.25M
2
ORCL icon
Oracle
ORCL
+$7.95M
3
JPM icon
JPMorgan Chase
JPM
+$4.47M
4
MU icon
Micron Technology
MU
+$4.07M
5
WELL icon
Welltower
WELL
+$3.56M

Sector Composition

Rank Sector Weight
1 Financials 25.48%
2 Technology 23.73%
3 Industrials 9.73%
4 Consumer Discretionary 6.41%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.76T
$10.4M 7.37%
55,930
-2,323
-4% -$432K
C icon
2
Citigroup
C
$223B
$9.8M 6.92%
83,966
+7,686
+10% +$798K
GS icon
3
Goldman Sachs
GS
$309B
$9.55M 6.75%
10,868
-311
-3% -$254K
AVGO icon
4
Broadcom
AVGO
$1.82T
$9.13M 6.45%
26,376
-6,418
-20% -$2.3M
MS icon
5
Morgan Stanley
MS
$337B
$9.02M 6.37%
50,818
-1,783
-3% -$297K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.99T
$8.62M 6.09%
27,527
+5,318
+24% +$1.52M
IBB icon
7
iShares Biotechnology ETF
IBB
$9.44B
$7.13M 5.03%
+42,219
New +$6.86M
NEM icon
8
Newmont
NEM
$98.5B
$6.82M 4.82%
68,328
-3,561
-5% -$322K
XLV icon
9
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$6.75M 4.77%
+43,630
New +$6.53M
RTX icon
10
RTX Corp
RTX
$294B
$6.6M 4.66%
35,989
-112
-0.3% -$19.5K
AAPL icon
11
Apple
AAPL
$4.95T
$6.54M 4.62%
+24,048
New +$6.46M
IJR icon
12
iShares Core S&P Small-Cap ETF
IJR
$110B
$4.26M 3.01%
+35,470
New +$4.24M
JPM icon
13
JPMorgan Chase
JPM
$947B
$3.89M 2.75%
12,070
-14,431
-54% -$4.47M
TSM icon
14
TSMC
TSM
$2.07T
$3.83M 2.71%
12,605
+11,785
+1,437% +$3.46M
BAC icon
15
Bank of America
BAC
$436B
$3.81M 2.69%
69,206
+4,204
+6% +$222K
CAT icon
16
Caterpillar
CAT
$402B
$3.72M 2.62%
6,485
-548
-8% -$305K
APH icon
17
Amphenol
APH
$184B
$3.66M 2.59%
27,100
-2,209
-8% -$295K
TJX icon
18
TJX Companies
TJX
$173B
$3.58M 2.53%
+23,338
New +$3.45M
PH icon
19
Parker-Hannifin
PH
$124B
$3.46M 2.44%
3,938
-19
-0.5% -$15.6K
CCJ icon
20
Cameco
CCJ
$38.9B
$3.45M 2.43%
37,673
-222
-0.6% -$20K
COR icon
21
Cencora
COR
$60.5B
$3.41M 2.41%
10,092
-5
-0% -$1.7K
XBI icon
22
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$3.28M 2.32%
+26,940
New +$3.09M
AMZN icon
23
Amazon
AMZN
$2.49T
$3.22M 2.27%
+13,946
New +$3.19M
TSLA icon
24
Tesla
TSLA
$1.22T
$2.27M 1.6%
5,051
-35
-0.7% -$15.5K
ILF icon
25
iShares Latin America 40 ETF
ILF
$3.79B
$2.1M 1.49%
+69,050
New +$2.06M

Similar funds

Marvin & Palmer Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Marvin & Palmer Associates held 36 positions worth $142M, up 5.2% from $135M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Marvin & Palmer Associates's Q4 2025 filing shows 9 new, 4 increased, 14 reduced and 9 closed positions. Its largest new stake was iShares Biotechnology ETF: 42,219 shares worth $7.13M. The largest sale was Interactive Brokers, an estimated $8.25M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • Marvin & Palmer Associates's largest Q4 2025 buy was iShares Biotechnology ETF: 42,219 shares worth $7.13M.
  • Marvin & Palmer Associates added most to TSMC in Q4 2025, an estimated $3.46M increase.
  • Marvin & Palmer Associates's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $4.47M.
  • Marvin & Palmer Associates fully exited Interactive Brokers in Q4 2025, selling an estimated $8.25M.
  • Marvin & Palmer Associates's ten largest holdings make up 59% of its $142M portfolio in Q4 2025.
  • Marvin & Palmer Associates opened 9 new positions and closed 9 in Q4 2025.
  • Marvin & Palmer Associates's portfolio value rose 5.2% quarter-over-quarter to $142M.

Based on Marvin & Palmer Associates's 13F filing for Q4 2025, filed 11 Feb 2026.